Triquetra Health has announced the launch of BioActive Vitamin B1 Clinical Strength, a new supplement designed to support nerve health, cellular energy, and metabolic wellness. The product delivers a 600mg dose of fat-soluble benfotiamine alongside a full cofactor protocol.
The formulation is intended to address conversion limitations common in single-ingredient B1 supplements. Standard thiamine requires magnesium to convert into thiamine pyrophosphate, its active functional form, which single-ingredient high-dose products often omit.
BioActive Vitamin B1 combines 600mg of benfotiamine with magnesium bis-glycinate, pyridoxal-5′-phosphate, and alpha-lipoic acid into a single system. The 600mg benfotiamine dose matches amounts utilized in published clinical research studies, including the BENDIP Phase III trial.
Pharmacokinetic research indicates that fat-soluble benfotiamine offers higher plasma thiamine bioavailability compared to standard thiamine hydrochloride. The supplement is delivered in vegetarian capsules and manufactured in facilities registered with the Food and Drug Administration.
BioActive Vitamin B1 Clinical Strength has been released and is currently available through Amazon and the company’s website. Third-party testing for purity and potency is conducted on the product line.
Follow us on social media
Facebook • Instagram • Tiktok • Newsbreak
Visit our other sites
Finding Connecticut • Finding New York City • Finding The Hudson Valley • Finding Lehigh Valley • Finding Westport
